Hindustan Organic Chemicals Ltd
Incorporated in 1960, Hindustan Organic Chemicals Ltd is in the business of bulk industrial chemicals and chemical intermediates[1]
- Market Cap ₹ 344 Cr.
- Current Price ₹ 51.2
- High / Low ₹ 55.6 / 21.0
- Stock P/E
- Book Value ₹ 163
- Dividend Yield 0.00 %
- ROCE -0.02 %
- ROE -1.79 %
- Face Value ₹ 10.0
Pros
- Stock is trading at 0.31 times its book value
- Company's median sales growth is 21.5% of last 10 years
Cons
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of 7.28% over past five years.
- Company has a low return on equity of -11.4% over last 3 years.
- Earnings include an other income of Rs.18.0 Cr.
- Working capital days have increased from 307 days to 505 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Commodity Chemicals
Part of BSE CPSE
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 149 | 108 | 142 | 239 | 464 | 294 | 404 | 434 | 631 | 704 | 536 | 574 | 506 | |
| 272 | 222 | 302 | 428 | 441 | 353 | 353 | 425 | 625 | 705 | 622 | 591 | 505 | |
| Operating Profit | -123 | -115 | -160 | -190 | 23 | -59 | 51 | 9 | 6 | -1 | -86 | -18 | 1 |
| OPM % | -83% | -106% | -112% | -80% | 5% | -20% | 13% | 2.1% | 1.0% | -0.1% | -16% | -3.1% | 0.1% |
| -33 | 15 | 6 | 66 | 115 | 22 | 20 | 31 | 12 | 17 | 526 | 26 | 18 | |
| Interest | 51 | 66 | 95 | 75 | 66 | 56 | 53 | 66 | 67 | 70 | 43 | 20 | 20 |
| Depreciation | 9 | 9 | 7 | 4 | 2 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 |
| Profit before tax | -215 | -174 | -256 | -203 | 71 | -95 | 16 | -26 | -50 | -55 | 395 | -14 | -4 |
| Tax % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 1% | -7% | |
| -215 | -174 | -256 | -203 | 71 | -95 | 16 | -26 | -50 | -55 | 392 | -13 | -3 | |
| EPS in Rs | -32.08 | -25.89 | -38.05 | -30.29 | 10.55 | -14.11 | 2.38 | -3.90 | -7.48 | -8.24 | 58.29 | -1.92 | -0.40 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 18% |
| 5 Years: | 7% |
| 3 Years: | -3% |
| TTM: | -21% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | % |
| 3 Years: | 17% |
| TTM: | 97% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 5% |
| 3 Years: | 13% |
| 1 Year: | 48% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | -15% |
| 3 Years: | -11% |
| Last Year: | -2% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 67 | 67 | 67 | 67 | 67 | 67 | 67 | 67 | 67 | 67 | 67 | 67 |
| Reserves | -871 | -1,048 | 80 | -20 | 59 | -38 | -7 | -17 | -60 | -56 | 1,038 | 1,029 |
| 672 | 682 | 596 | 602 | 602 | 516 | 429 | 1,127 | 1,186 | 1,262 | 115 | 194 | |
| 428 | 543 | 1,065 | 981 | 793 | 798 | 908 | 281 | 272 | 299 | 336 | 258 | |
| Total Liabilities | 296 | 243 | 1,807 | 1,631 | 1,521 | 1,342 | 1,397 | 1,458 | 1,465 | 1,572 | 1,555 | 1,548 |
| 117 | 101 | 1,637 | 102 | 120 | 126 | 136 | 155 | 165 | 226 | 227 | 231 | |
| CWIP | 11 | 4 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 1 |
| Investments | 9 | 9 | 9 | 11 | 11 | 3 | 8 | 11 | 10 | 18 | 14 | 24 |
| 160 | 129 | 158 | 1,518 | 1,390 | 1,213 | 1,253 | 1,293 | 1,290 | 1,328 | 1,310 | 1,292 | |
| Total Assets | 296 | 243 | 1,807 | 1,631 | 1,521 | 1,342 | 1,397 | 1,458 | 1,465 | 1,572 | 1,555 | 1,548 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -113 | 47 | 64 | -342 | -157 | -82 | 18 | 12 | -13 | -66 | 631 | -70 | |
| 5 | -1 | 1 | 343 | 112 | 164 | 7 | 9 | 7 | 56 | 10 | 12 | |
| 85 | -46 | -63 | 71 | -0 | -90 | -16 | -33 | -10 | 6 | -642 | 58 | |
| Net Cash Flow | -23 | 0 | 1 | 73 | -45 | -8 | 9 | -13 | -16 | -4 | -1 | -0 |
| Free Cash Flow | -109 | 45 | 64 | 0 | -49 | 74 | 18 | 11 | -14 | -67 | 624 | -72 |
| CFO/OP | 92% | -41% | -40% | 180% | -668% | 139% | 35% | 128% | -203% | 6,570% | -733% | 401% |
Ratios
Standalone / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 54 | 22 | 13 | 7 | 14 | 10 | 2 | 6 | 10 | 10 | 10 | 5 |
| Inventory Days | 222 | 263 | 368 | 180 | 70 | 94 | 99 | 109 | 44 | 53 | 52 | 44 |
| Days Payable | 444 | 972 | 1,179 | 520 | 135 | 67 | 30 | 57 | 34 | 50 | 42 | 14 |
| Cash Conversion Cycle | -168 | -687 | -798 | -333 | -51 | 37 | 72 | 58 | 21 | 12 | 20 | 35 |
| Working Capital Days | -786 | -1,579 | -3,255 | 473 | 306 | 171 | 32 | -50 | -93 | -142 | 558 | 505 |
| ROCE % | -72% | -19% | 15% | -6% | 13% | 5% | 1% | 1% | -5% | -0% |
Insights
In beta| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Acetone Production MT |
|
|||||||||
| Hydrogen Peroxide Production MT |
||||||||||
| Phenol Production MT |
||||||||||
| Phenol Plant Capacity Utilization % |
||||||||||
| Hydrogen Peroxide Plant Capacity Utilization % |
||||||||||
Extracted by Screener AI
Documents
Announcements
-
Scrutinizer Report Of 65Th AGM.
- HOCL filed 65th AGM voting results and scrutinizer report; 6 resolutions passed on 25 September 2026.
-
Closure of Trading Window
- Trading window closed from 1 October 2026 until 48 hours after Q2 FY27 results.
-
Clarification On Price Movement.
- HOCL says two consecutive profit quarters in FY26, first since FY2020-21, may explain recent share price movement.
-
Clarification sought from Hindustan Organic Chemicals Ltd
- Exchange has sought clarification from Hindustan Organic Chemicals Ltd on September 25, 2026 with reference to significant movement in price, in order to ensure that …
- Shareholder Meeting / Postal Ballot-Outcome of AGM
Annual reports
-
Annual Report 2026
from bse
-
Annual Report 2025
from bse
-
Annual Report 2024
from bse
-
Annual Report 2023
from bse
-
Annual Report 2022
from bse
-
Annual Report 2021
from bse
-
Annual Report 2020
from bse
-
Annual Report 2019
from bse
-
Annual Report 2018
from bse
-
Annual Report 2017
from bse
-
Annual Report 2016
from bse
-
Annual Report 2015
from bse
-
Annual Report 2014
from bse
-
Annual Report 2013
from bse
-
Annual Report 2012
from bse
Business Overview:[1][2]
HOCL was set up as a Government of India enterprise (government holds ~ 58.78% equity stake) under the administrative control of Ministry of Chemicals and Fertilizers. It is the 2nd largest producer of Phenol and Acetone
in India. Company manufactures Hydrogen Peroxide. The raw materials used by HOCL are Benzene and LPG, which come from petroleum refineries. Currently, 500+ units based on HOC’s products are setup across India. It also produces versatile engineering plastic polytetrafluoroethylene (PTFE) through its subsidiary viz. Hindustan Flurocarbons Limited (HFL)